Ocugen (OCGN) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

OCGN Stock Forecast


Ocugen stock forecast is as follows: an average price target of $5.00 (represents a 545.74% upside from OCGN’s last price of $0.77) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.

OCGN Price Target


The average price target for Ocugen (OCGN) is $5.00 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $6.00 to $3.50. This represents a potential 545.74% upside from OCGN's last price of $0.77.

OCGN Analyst Ratings


Buy

According to 6 Wall Street analysts, Ocugen's rating consensus is 'Buy'. The analyst rating breakdown for OCGN stock is 0 'Strong Buy' (0.00%), 6 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Ocugen Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 23, 2022Uy EarMizuho Securities$5.00$2.34113.68%545.74%
Aug 15, 2022H.C. Wainwright$6.00$2.88108.33%674.89%
Jun 18, 2022Jennifer KimCantor Fitzgerald$4.50$2.16108.33%481.17%
May 08, 2022Daniil GataulinChardan Capital$3.50$2.1662.04%352.02%
Apr 25, 2022Zegbeh JallahRoth Capital$6.00$2.40150.00%674.89%

The latest Ocugen stock forecast, released on Aug 23, 2022 by Uy Ear from Mizuho Securities, set a price target of $5.00, which represents a 113.68% increase from the stock price at the time of the forecast ($2.34), and a 545.74% increase from OCGN last price ($0.77).

Ocugen Price Target by Period


1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.77$0.77$0.77
Upside/Downside-100.00%-100.00%-100.00%

In the current month, the average price target of Ocugen stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Ocugen's last price of $0.77. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Oct 15, 2024Maxim GroupBuyInitialise
May 15, 2024H.C. WainwrightBuyBuyHold
Mar 01, 2023Cowen & Co.OutperformInitialise
Jun 18, 2022Cantor FitzgeraldOverweightOverweightInitialise
Apr 25, 2022Roth CapitalBuyBuyHold
Jun 07, 2021Roth CapitalBuyBuyHold
Feb 27, 2021H.C. WainwrightBuyBuyUpgrade
Feb 09, 2021Chardan CapitalBuyDowngrade
Feb 08, 2021Cantor FitzgeraldOverweightOverweightHold
Feb 06, 2021H.C. WainwrightBuyUpgrade
Feb 06, 2021Roth CapitalBuyBuyHold

Ocugen's last stock rating was published by Maxim Group on Oct 15, 2024. The company Initialise its OCGN rating from "null" to "Buy".

Ocugen Financial Forecast


Ocugen Revenue Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Dec 22Mar 22Mar 21
Revenue----------
Avg Forecast$1.14M$1.14M$1.14M$1.14M$400.00K$400.00K$1.14M$2.17M$13.87M$39.04M
High Forecast$1.14M$1.14M$1.14M$1.14M$400.00K$400.00K$1.14M$2.17M$13.87M$39.04M
Low Forecast$1.14M$1.14M$1.14M$1.14M$400.00K$400.00K$1.14M$2.17M$13.87M$39.04M
# Analysts1111211111
Surprise %----------

Ocugen's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. OCGN's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).

Ocugen EBITDA Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Dec 22Mar 22Mar 21
# Analysts1111211111
EBITDA-------$-24.15M$-17.96M$-7.01M
Avg Forecast$-227.20K$-227.20K$-227.20K$-227.20K$-80.00K$-80.00K$-228.20K$-433.33K$-2.77M$-13.13M
High Forecast$-227.20K$-227.20K$-227.20K$-227.20K$-80.00K$-80.00K$-228.20K$-433.33K$-2.77M$-10.50M
Low Forecast$-227.20K$-227.20K$-227.20K$-227.20K$-80.00K$-80.00K$-228.20K$-433.33K$-2.77M$-15.75M
Surprise %-------55.73%6.48%0.53%

undefined analysts predict OCGN's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Ocugen's previous annual EBITDA (undefined) of $NaN.

Ocugen Net Income Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Dec 22Mar 22Mar 21
# Analysts1111211111
Net Income-------$-19.73M$-18.00M$-7.08M
Avg Forecast$-20.32M$-18.87M$-18.87M$-17.42M$-15.96M$-15.96M$-13.73M$-29.03M$3.43M$-13.25M
High Forecast$-20.32M$-18.87M$-18.87M$-17.42M$-15.96M$-15.96M$-13.73M$-29.03M$3.43M$-10.60M
Low Forecast$-20.32M$-18.87M$-18.87M$-17.42M$-15.96M$-15.96M$-13.73M$-29.03M$3.43M$-15.90M
Surprise %-------0.68%-5.25%0.53%

Ocugen's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. OCGN's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Ocugen SG&A Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Dec 22Mar 22Mar 21
# Analysts1111211111
SG&A-------$6.94M$10.12M$4.18M
Avg Forecast$47.37M$47.37M$47.37M$47.37M$16.68M$16.68M$47.58M$90.35M$578.27M$7.83M
High Forecast$47.37M$47.37M$47.37M$47.37M$16.68M$16.68M$47.58M$90.35M$578.27M$9.40M
Low Forecast$47.37M$47.37M$47.37M$47.37M$16.68M$16.68M$47.58M$90.35M$578.27M$6.27M
Surprise %-------0.08%0.02%0.53%

Ocugen's average Quarter SG&A projection for Jun 24 is $47.58M, based on 1 Wall Street analysts, with a range of $47.58M to $47.58M. The forecast indicates a 585.91% rise compared to OCGN last annual SG&A of $6.94M (Dec 22).

Ocugen EPS Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Dec 22Mar 22Mar 21
# Analysts1111211111
EPS-------$-0.09$-0.09$-0.04
Avg Forecast$-0.07$-0.07$-0.07$-0.06$-0.06$-0.06$-0.05$-0.10$0.01$0.19
High Forecast$-0.07$-0.07$-0.07$-0.06$-0.06$-0.06$-0.05$-0.10$0.01$0.19
Low Forecast$-0.07$-0.07$-0.07$-0.06$-0.06$-0.06$-0.05$-0.10$0.01$0.19
Surprise %-------0.90%-6.56%-0.21%

According to undefined Wall Street analysts, Ocugen's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to OCGN previous annual EPS of $NaN (undefined).

Ocugen Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
HEPAHepion Pharmaceuticals$0.52$70.0013361.54%Buy
ELEVElevation Oncology$0.67$9.001243.28%Buy
OCGNOcugen$0.83$5.00502.41%Buy
ZURAZura Bio$2.51$10.00298.41%Buy
VXRTVaxart$0.59$2.00238.98%Hold
NVAXNovavax$9.00$20.33125.89%Buy

OCGN Forecast FAQ


Is Ocugen a good buy?

Yes, according to 6 Wall Street analysts, Ocugen (OCGN) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 6 'Buy' recommendations, accounting for 100.00% of OCGN's total ratings.

What is OCGN's price target?

Ocugen (OCGN) average price target is $5 with a range of $3.5 to $6, implying a 545.74% from its last price of $0.774. The data is based on 6 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Ocugen stock go up soon?

According to Wall Street analysts' prediction for OCGN stock, the company can go up by 545.74% (from the last price of $0.774 to the average price target of $5), up by 674.89% based on the highest stock price target, and up by 352.02% based on the lowest stock price target.

Can Ocugen stock reach $1?

OCGN's average twelve months analyst stock price target of $5 supports the claim that Ocugen can reach $1 in the near future.

What are Ocugen's analysts' financial forecasts?

Ocugen's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $1.94M (high $1.94M, low $1.94M), average EBITDA is $-388K (high $-388K, low $-388K), average net income is $-45.654M (high $-45.654M, low $-45.654M), average SG&A $80.94M (high $80.94M, low $80.94M), and average EPS is $-0.163 (high $-0.163, low $-0.163). OCGN's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $4.54M (high $4.54M, low $4.54M), average EBITDA is $-909K (high $-909K, low $-909K), average net income is $-75.468M (high $-75.468M, low $-75.468M), average SG&A $189.49M (high $189.49M, low $189.49M), and average EPS is $-0.26 (high $-0.26, low $-0.26).